Delivered as a Hybrid Event
September 19-20, 2022Boston, MAkeyboard_arrow_right
Search keyboard_arrow_right
keyboard_arrow_left Hide
DAY 1 ✦ LIVE ✦ Mon, Sep 20 - EDT
search
DAY 1 ✦ LIVE ✦ Mon, Sep 20 - EDT
search
7:45am - 8:45am60 mins
Future of Finance — Digital Transformation and Innovative Technologies
- Joe Goldberg - National Life Sciences Industry Consulting Leader, RSM US LLP
9:00am - 9:15am15 mins
Welcome and Opening Remarks by Conference Chairperson and Conference Producer
- Nancy Aubrey - Partner, Biopharma Sector Co-Leader, RSM US LLP
- Michelle Benz - Conference Producer, Pharma & Life Sciences, Informa Connect
9:15am - 9:45am30 mins
Public Policy Critical Update — Financial Impact of Proposed & Enacted Legislation
- Matthew DeNoncour, Esq. - Principal Attorney & Owner, Magis Law Firm, P.C.
- Satya Thallam - Vice President, Policy and Advocacy, and Government and Policy Practice Lead, EQRx
9:45am - 10:30am45 mins
The Changing Landscape of Clinical Trials
- Justin Culbertson, CPA - Life Sciences Senior Analyst, RSM US LLP
- Timothy Schroeder - CEO, CTI Clinical Trial and Consulting Services
- Jim Datin - President & Chief Executive Officer, BioAgilytix Labs
10:30am - 11:00am30 mins
Fresh Air and Networking Break
11:00am - 11:45am45 mins
CFO FIRESIDE CHAT ● Path to the CFO Role, Lessons on Leadership and Tackling Challenges
- Bethany Sensenig - Chief Financial Officer & Head of US Operations, Minovia Therapeutics
- Andrew Sassine, MBA - Chief Financial Officer and Board of Director, Arcturus Therapeutics, Inc.
- John Crowley - Chief Financial Officer, Fusion Pharmaceuticals
11:45am - 12:30pm45 mins
Product Launch Planning
- Joe Goldberg - National Life Sciences Industry Consulting Leader, RSM US LLP
- Maggie Berkeley - Principal, Risk Consulting, Biopharma Sector Co-leader, RSM US LLP
- Tom Evegan - Principal, Strategy & Management Consulting, RSM US LLP
12:30pm - 1:30pm60 mins
Networking Luncheon and Roundtable Discussions
1:30pm - 2:15pm45 mins
Biotech Equity Funding Models and Pathways — Venture Capital and the Public Markets
- Andrew Sassine, MBA - Chief Financial Officer and Board of Director, Arcturus Therapeutics, Inc.
- Joseph Thome, PhD - Director, Senior Biotechnology Equity Research Analyst, Cowen and Company
- Teri Loxam - Chief Financial Officer, SQZ Biotechnologies
- Jeffrey Baumel - Partner, Dentons
2:15pm - 3:00pm45 mins
4 Truths About Hiring
- Jake Stebbins - Senior Consultant Life Sciences, TriNet
- Jim Christino - Area Vice President, TriNet
3:00pm - 3:30pm30 mins
Fresh Air and Networking Break
3:30pm - 4:15pm45 mins
Forecasting, Modeling and Valuation Strategies for Life Science Companies
- Ryan Starkes, CPA - Partner, Centri Business Consulting
- Charles Higgins, CFA - Director, Centri Business Consulting, LLC
4:15pm - 5:15pm60 mins
Opening Night Reception